Results of individual patient dosimetry in peptide receptor radionuclide therapy with 177Lu DOTA-TATE and 177Lu DOTA-NOC - Wehrmann, C; Senftleben, S; Zachert, C (Cancer Biother Radiopharm, 2007)
et al.